Abound Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$212K Sell
1,649
-57
-3% -$6.67K 0.04% 98
2026
Q1
$205K Buy
1,706
+152
+10% +$17.5K 0.05% 89
2025
Q4
$164K Buy
1,554
+99
+7% +$9.29K 0.04% 98
2025
Q3
$122K Sell
1,455
-1,465
-50% -$121K 0.03% 118
2025
Q2
$231K Buy
2,920
+510
+21% +$40.5K 0.07% 68
2025
Q1
$216K Buy
2,410
+1,455
+152% +$136K 0.07% 65
2024
Q4
$95K Sell
955
-237
-20% -$24.4K 0.03% 109
2024
Q3
$135K Buy
1,192
+156
+15% +$18.5K 0.05% 84
2024
Q2
$128K Sell
1,036
-69
-6% -$8.89K 0.05% 74
2024
Q1
$146K Sell
1,105
-786
-42% -$96.9K 0.06% 71
2023
Q4
$206K Sell
1,891
-24
-1% -$2.49K 0.08% 58
2023
Q3
$197K Buy
1,915
+34
+2% +$3.67K 0.08% 52
2023
Q2
$217K Buy
1,881
+176
+10% +$20K 0.09% 49
2023
Q1
$181K Buy
1,705
+141
+9% +$15.2K 0.08% 54
2022
Q4
$174K Sell
1,564
-17
-1% -$1.74K 0.09% 51
2022
Q3
$136K Buy
+1,581
New +$141K 0.07% 49

Other funds holding MRK

Abound Wealth Management's MRK Position: Q2 2026 in Review

Abound Wealth Management reduced its Merck (MRK) stake by 3.3% in Q2 2026, selling an estimated $6.67K and leaving 1,649 shares worth $212K. The position accounts for 0.04% of the portfolio, ranked #98.

Abound Wealth Management first reported a position in MRK in Q3 2022 and has held it in 16 quarters since. The position peaked at $231K in Q2 2025. 1,532 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Abound Wealth Management held 1,649 shares of Merck worth $212K as of Q2 2026.
  • Abound Wealth Management sold 57 Merck shares in Q2 2026, an estimated $6.67K.
  • Merck made up 0.04% of Abound Wealth Management's portfolio in Q2 2026, its #98 holding.
  • Abound Wealth Management first reported a position in Merck in Q3 2022 and has held it in 16 quarters since.
  • Abound Wealth Management's Merck position peaked at $231K in Q2 2025.
  • 1,532 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.